CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cytrx's Quick Ratio

CYTR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




CYTR Quick Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Change -24.31 % -91.67 % -89.54 % -91.51 % -89.78 %
Y / Y Cash & cash equivalent Change -24.94 % -46.8 % -42.87 % -43.22 % -46.37 %
Quick Ratio MRQ 8.43 21.12 14.14 8.34 8.5
Overall Ranking # 295 # 128 # 210 # 399 # 425
Seq. Current Liabilities Change 139.27 % -35.29 % -44.69 % -11.62 % -73.66 %
Seq. Cash & cash equivalent Change -4.45 % -3.36 % -6.18 % -13.36 % -32.28 %



Quick Ratio third quarter 2019 Comment
Due to increase in Current Liabilities in the third quarter 2019, Quick Ratio fell to 8.43 below Cytrx Corp average.

Within Biotechnology & Drugs industry 30 other companies have achieved higher Quick Ratio than Cytrx in third quarter 2019. While Quick Ratio total ranking has deteriorated compare to previous quarter from 128 to 295.

Explain Quick Ratio?
What are CYTR Segments?
See Quick Ratio CYTR on the trailing twelve month basis
Quick Ratio third quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 31
Healthcare Sector # 112
Overall Market # 295


Quick Ratio Statistics
High Average Low
21.12 4.39 1.01
(Jun 30 2019)   (Jun 30 2012)




Financial Statements
Cytrx's Current Liabilities $ 2 Millions Visit CYTR's Balance sheet
Cytrx's Cash & cash equivalent $ 19 Millions Visit CYTR's Balance sheet
Source of CYTR's Sales Visit CYTR's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2019, within Biotechnology & Drugs Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Fennec Pharmaceuticals Inc.  16.84 $ 15.240  Millions$ 0.905  Millions
Eidos Therapeutics, Inc.  16.46 $ 165.822  Millions$ 10.075  Millions
Homology Medicines, Inc.  14.43 $ 269.672  Millions$ 18.682  Millions
Repligen Corp  14.37 $ 513.454  Millions$ 35.721  Millions
Audentes Therapeutics, inc.  14.37 $ 351.464  Millions$ 24.455  Millions
Cannabics Pharmaceuticals Inc.  14.30 $ 6.277  Millions$ 0.439  Millions
G1 Therapeutics, Inc.  14.13 $ 299.933  Millions$ 21.222  Millions
Iovance Biotherapeutics, inc.  13.79 $ 361.874  Millions$ 26.243  Millions
Jounce Therapeutics, Inc.  13.21 $ 175.800  Millions$ 13.308  Millions
Cohbar, Inc.  12.07 $ 14.420  Millions$ 1.195  Millions
Aerpio Pharmaceuticals, Inc.  12.05 $ 43.390  Millions$ 3.601  Millions
Oxford Immunotec Global Plc  11.02 $ 184.282  Millions$ 16.728  Millions
Lixte Biotechnology Holdings, Inc.  10.88 $ 2.976  Millions$ 0.274  Millions
Scpharmaceuticals Inc.  10.84 $ 83.562  Millions$ 7.711  Millions
Enochian Biosciences Inc  10.66 $ 11.138  Millions$ 1.045  Millions
Denali Therapeutics Inc.  10.27 $ 479.390  Millions$ 46.685  Millions
Evelo Biosciences, Inc.  10.03 $ 97.061  Millions$ 9.675  Millions
Organovo Holdings, Inc.  9.72 $ 30.350  Millions$ 3.122  Millions
Catalyst Biosciences, Inc.  9.36 $ 84.950  Millions$ 9.077  Millions
Casi Pharmaceuticals, Inc.  9.18 $ 63.798  Millions$ 6.948  Millions
Adverum Biotechnologies, Inc.  9.13 $ 161.985  Millions$ 17.746  Millions
Arcus Biosciences, Inc.  9.07 $ 190.989  Millions$ 21.057  Millions
Pulse Biosciences, Inc.  8.91 $ 34.498  Millions$ 3.870  Millions
Aptose Biosciences Inc.  8.90 $ 30.214  Millions$ 3.395  Millions
Sienna Biopharmaceuticals, Inc.  8.77 $ 11.332  Millions$ 1.292  Millions
Cytrx Corp  8.43 $ 18.515  Millions$ 2.196  Millions
Eyenovia, Inc.  8.42 $ 18.414  Millions$ 2.187  Millions
Arca Biopharma, Inc.  8.39 $ 9.645  Millions$ 1.150  Millions
Crispr Therapeutics Ag  7.89 $ 629.717  Millions$ 79.779  Millions
Unity Biotechnology, Inc.  7.89 $ 112.974  Millions$ 14.318  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CGA's Profile

Stock Price

CGA's Financials

Business Description

Fundamentals

Charts & Quotes

CGA's News

Suppliers

CGA's Competitors

Customers & Markets

Economic Indicators

CGA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071